Research Article |
Corresponding author: Theerasak Rojanarata ( rojanarata_t@silpakorn.edu ) Academic editor: Ivanka Pencheva
© 2024 Thana Thanayutsiri, Prasopchai Patrojanasophon, Praneet Opanasopit, Tanasait Ngawhirunpat, Theerasak Rojanarata.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Thanayutsiri T, Patrojanasophon P, Opanasopit P, Ngawhirunpat T, Rojanarata T (2024) A novel, green and affordable semi-quantitative limit test for 2-aminobutanol impurity in ethambutol hydrochloride bulk and tablets. Pharmacia 71: 1-7. https://doi.org/10.3897/pharmacia.71.e124137
|
The pharmacopoeial limit test for the impurity 2-aminobutanol (AB) in ethambutol hydrochloride (ETB) relies on florescence measurement using a fluorometer. However, this instrument is often unavailable in many laboratories due to its cost. A novel colorimetric method was therefore developed using genipin, an amine-reactive reagent, to react with AB, producing a blue color. The color intensity was subsequently measured using a more affordable UV-vis spectrophotometer. To overcome matrix effects, the standard addition technique was incorporated. The test effectively detected AB at concentrations as low as 0.125% in ETB, below the compendial limit of 1.0%. The analysis of ETB bulk and tablets showed consistent semi-quantitative results with the USP method. Furthermore, it aligned with green chemistry by eliminating the use of organic solvents and employing safe, naturally derived reagent. In summary, the proposed method provides a reliable, green, and cost-effective alternative for analyzing AB in ETB, ensuring compliance with pharmacopeial standards.
limit test, 2-aminobutanol, ethambutol hydrochloride, UV-vis spectrophotometry, genipin
A limit test, as defined by pharmacopoeias, is an analytical procedure used to assess the presence of impurities in pharmaceutical active ingredients or products. The primary objective of this type of test is to determine whether the level of a particular impurity within a drug substance or product falls within an acceptable range established by regulatory authorities or pharmacopoeial standards. Accordingly, limit tests play an essential role in pharmaceutical quality control, as it helps to ensure the safety, efficacy, and purity of drug products.
Ethambutol (ETB), an antibiotic drug used for the treatment of tuberculosis, may contain 2-aminobutanol (AB) as a known impurity originating from the synthesis process. To this end, pharmacopoeias establish limits for AB in ETB bulk drug and formulations, typically set at 1.0% (
While the procedure of the pharmacopeial AB limit test is not too complicated, in practice, performing this test can be problematic for many laboratories due to the lack of a fluorometer since this instrument is relatively expensive. In the pursuit of other previously reported methods used for analyzing AB in various sample types, non-aqueous titration is found to be as an option (
AB (purity of 99.7%), ETB (purity of 100%) and fluorescamine were purchased from Sigma (MO, USA). Genipin was obtained from Challenge Bioproducts Co., Ltd. (Taichung, Taiwan). ETB tablets (400 mg per tablet) were obtained from a drugstore in Thailand. Other ingredients in the tablets included microcrystalline cellulose, corn starch, anhydrous lactose, colloidal silicon dioxide and talc. UV-vis spectrophotometer (Cary 60 UV-Vis Spectrophotometer, Agilent Technologies, Germany) was used for the absorbance measurement in the proposed limittest, and spectrofluorophotometer (RF-6000, Shimadzu, Japan) was used for measuring the fluorescence intensity following the USP method.
Initially, a stock standard solution of AB at a concentration of 0.1 mg/mL was prepared in water, while a 10 mM genipin solution was made by dissolving genipin in 0.1 M potassium phosphate buffer, pH 8.0. The ETB sample solution was prepared by dissolving either ETB bulk or ground ETB tablets in water to have an ETB concentration of 4 mg/mL. In the case of tablet-derived solutions, they underwent filtration through a 0.45 µm filter to eliminate insoluble excipients before proceeding with the reaction.
To perform the analysis, 500 μL of sample solution was dispensed into two separate 1.5 mL microcentrifuge tubes using a micropipette. In the first tube, referred to as NS (no standard AB), 500 μL of water was added, resulting in the solution containing only 2 mg/mL ETB. In the second tube, labeled as SA (standard addition), 200 µL of 0.1 mg/mL standard AB solution and 300 µL of water were added, yielding a solution with 2 mg/mL ETB and 0.02 mg/mL AB. To each tube, 200 μL of 10 mM genipin solution was added. The solutions were thoroughly mixed and subsequently heated in a water bath at 80 °C for 15 min. Following cooling on ice for 1 min, the solutions were subjected to absorbance measurements at 590 nm utilizing a UV-vis spectrophotometer. The acceptance criterion for the limit test was that the absorbance of the NS solution was not greater than the difference between the absorbances of the SA solution and NS solution (NS < SA-NS).
Before the above-mentioned protocol had been established, an investigation was conducted to establish whether a chromogenic reagent, genipin, could be used as an alternative for the fluorogenic fluorescamine. To this end, genipin was tested for its capability to generate blue colored products with AB both in the absence and presence of ETB. In these experiments, excess amounts of the colorimetric reagent, specifically 7.5 mM genipin, was used to react with 0.01 mg/ml AB solution, 1 mg/mL ETB solution, and a mixture solution of 0.01 mg/ml AB and 1 mg/mL ETB (equal to 1% AB in ETB). Subsequent to the reactions, the absorbance of the solutions was measured at the wavelength of 590 nm.
The effects of the concentration of genipin stock solution (5, 10, 15 mM), reaction’s pH (7, 8, 9), and heating duration (10, 15, 20 min) on the development of blue color were examined using AB in the range of 0.01–0.05 mg/mL, alongside the presence of 2 mg/mL ETB. The optimal condition, which yielded a standard curve of AB with a steeper slope and enabled a faster and more reagent-saving test compared to the others, was selected for establishing the protocol.
The proposed method was validated according to the guidelines outlined in USP 43〈1225〉 VALIDATION OF COMPENDIAL PROCEDURES for a semi-quantitative limit test (Category II) (The United States Pharmacopoeia Convention 2020). The specificity of the test was confirmed by investigating the interference effects of ETB drug and the tablet excipients, i.e., microcrystalline cellulose, corn starch, anhydrous lactose, colloidal silicon dioxide and talc. The linear relationship between the concentration of AB (X), ranging from 0.01–0.05 mg/mL in the presence of 2 mg/mL ETB (to simulate the real samples), and the absorbance at 590 nm (Y) was examined by plotting a standard curve. Subsequently, the regression equation and the coefficient of determination (r2) were determined. The detection limit was calculated based on 3.3 times the standard deviation of the response divided by the slope of the standard curve.
The proposed method was applied for semi-quantitative analysis of AB in the real samples, i.e., ETB chemical bulks and commercial tablets (400 mg/tablet). Since AB levels in these samples were normally below 1% as they had undergone quality control checks prior to their release and marketing, synthetic samples were additionally made and tested to verify the reliability of the test. This involved adding varying amounts of AB (both exceeding and falling below 1%) to the commercial samples and subsequently conducting the analysis. Finally, the results obtained from the proposed method were compared with those from the USP method.
In light of AB containing a primary amine whereas ETB does not, a chromogenic reagent specifically reacting with this functional group was explored for the development of a new colorimetric method. Additionally, since the greenness of the method was concerned, with a particular emphasis on the safety of the reagent and the avoidance of organic solvents, a test enabled in an aqueous medium was preferred. Consequently, ninhydrin, a well-known chromogenic chemical was excluded from the study due to its relatively unsafe nature and its typical use in organic solvents such as acetone, ethanol, or N, N-dimethylformamide. Considering genipin’s ability to react with primary amines (as illustrated in Fig.
From the experiments, it was revealed that the reaction of genipin and AB in water produced an intense blue color, evidenced by the high absorbance at 590 nm (Fig.
The absorbance and fluorescence intensity of the solutions (n = 3) resulting from the reactions between genipin (a) or fluorescamine (b), respectively, with 0.01 mg/ml 2-aminobutanol (AB) solution, 1 mg/mL ethambutol hydrochloride (ETB) solution, and a mixture solution of 0.01 mg/ml AB and 1 mg/mL ETB (AB+ETB).
As illustrated in Fig.
The validation results (studied in the presence of 2 mg/mL ETB) demonstrated a good linear relationship between the concentration of AB and the absorbance, with a regression equation y = 22.331x - 0.0019 and r2 of 0.9985. The detection limit for AB was determined to be 0.0025 mg/mL, indicating that the method could effectively detect the impurity at a level as low as 0.125% (0.125 mg AB in 100 mg ETB). This detection limit is below the pharmacopoeial limit (1.0%) set for both ETB bulk and tablets. Regarding specificity, the method was unaffected by the tablet excipients tested, as these ingredients lack amine groups to react with genipin or produce the blue color. However, despite ETB lacking amine groups, it interfered with the test by lowering the intensity of the blue color. This interference was seen by the reduction of slope of the standard curve obtained from samples containing ETB compared to those without ETB (Fig.
The analysis results of AB in both the commercial samples and the synthetic samples (commercial samples supplemented with additional AB) are presented in Table
Results of semi-quantitative limit test for 2-aminobutanol (AB) in ethambutol (ETB) samples.
ETB sample | Proposed method (genipin) | USP method (fluorescamine) | ||||||
---|---|---|---|---|---|---|---|---|
Absorbance | Conclusiona | Fluorescence intensity | Conclusionb | |||||
NS solution | SA solution | Difference | NS solution | SA solution | Difference | |||
Bulk | ||||||||
Original sample | 0.098 | 0.478 | 0.379 | Pass | 1462 | 3115 | 1654 | Pass |
Synthetic samples | ||||||||
Bulk + 0.9% AB added | 0.350 | 0.730 | 0.381 | Pass | 1719 | 3451 | 1732 | Pass |
Bulk + 0.95% AB added | 0.383 | 0.762 | 0.380 | Reject | 1827 | 3526 | 1698 | Reject |
Bulk + 1.0% AB added | 0.400 | 0.790 | 0.390 | Reject | 1900 | 3583 | 1683 | Reject |
Bulk + 1.05% AB added | 0.428 | 0.810 | 0.382 | Reject | 1979 | 3676 | 1698 | Reject |
Bulk + 1.1% AB added | 0.449 | 0.831 | 0.382 | Reject | 2044 | 3769 | 1725 | Reject |
Tablets | ||||||||
Original sample | 0.036 | 0.435 | 0.399 | Pass | 389.052 | 2246.128 | 1857 | Pass |
Synthetic samples | ||||||||
Tablets + 0.9% AB added | 0.386 | 0.816 | 0.430 | Pass | 1718.971 | 3549.880 | 1831 | Pass |
Tablets + 0.95% AB added | 0.406 | 0.842 | 0.435 | Pass | 1848.690 | 3712.807 | 1864 | Pass |
Tablets + 1.0% AB added | 0.435 | 0.866 | 0.431 | Reject | 2024.844 | 3868.151 | 1843 | Reject |
Tablets + 1.05% AB added | 0.460 | 0.890 | 0.430 | Reject | 2193.672 | 4014.129 | 1820 | Reject |
Tablets + 1.1% AB added | 0.483 | 0.915 | 0.432 | Reject | 2356.443 | 4209.773 | 1853 | Reject |
The limit test using genipin developed in this work presented numerous advantages over the USP method, particularly in terms of affordable and practical operations as well as alignment with green chemistry. By switching from fluorometry to colorimetry, laboratories can use UV-spectrophotometers, which are more commonly available and cost-effective instruments, instead of fluorometers. Besides, while it is essential to promptly determine the fluorescence intensity after a timely 1-min incubation of the fluorescamine reaction, as indicated in the USP test instructions, the absorbance measurement in the proposed method allows for greater flexibility, as the intensity of the blue color remains stable and unchanged for at least 30 min after complete formation (Fig.
In regards to greenness, the test was conducted in water without the need for organic solvents like acetone, which is used as a solvent for fluorescamine in the USP method. Additionally, genipin is favored for green chemistry as it is derived from natural sources e.g. gardenia fruit and is considered a safe and environmentally friendly substance (
This study presents a novel semi-quantitative limit test for AB in ETB bulk and tablets. The method relied on a colorimetric reaction between genipin and primary amines of AB, with the intensity of the resulting blue color being measured spectrophotometrically at 590 nm. To address the matrix effects, especially those attributed to ETB, the standard addition technique was incorporated. Despite changing from fluorometry to colorimetry, the method exhibited adequate sensitivity, capable of detecting AB at levels eight times lower than the pharmacopeial limit of 1%, and it gave the consistent analysis results with those obtained from the USP method. The method provided enhanced flexibility for conducting the reaction and subsequent absorbance measurement since the blue color formed was remarkably stable. Additionally, a greener reagent and required less expensive instrumentation were used in the test. Although the test required a 15-min heating step, the simultaneous analysis of multiple samples could decrease energy expenses and overall runtime. In summary, the proposed method provided a reliable alternative method for the analysis of AB in ETB samples, ensuring compliance with pharmacopeial standards.
The authors declare that there is no conflict of interest.
This research was supported by the Faculty of Pharmacy, Silpakorn University, through the research grant RG 003/2567.